A randomized study of pomalidomide vs placebo in persons with myeloproliferative neoplasm-associated myelofibrosis and RBC-transfusion dependence

Leukemia. 2017 May;31(5):1252. doi: 10.1038/leu.2017.2.
No abstract available

Publication types

  • Published Erratum